
Euroapi Investor Relations Material
Latest events

H1 2025
Euroapi
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Euroapi S.A.
Access all reports
Euroapi S.A., operating under the brand EUROAPI, is a global leader in the production of active pharmaceutical ingredients (APIs). The company boasts an extensive portfolio of over 200 products, serving the healthcare industry by developing, manufacturing, and distributing APIs and intermediates. These ingredients are crucial for the formulation of medicines intended for both human and veterinary use, catering to a broad spectrum of therapeutic areas including small molecules, lipids, microbial fermentation, and more. EUROAPI's offerings also encompass Contract Development and Manufacturing Organization (CDMO) services. The company is headquartered in Paris, France, and its shares are listed on the Euronext Paris stock exchange.
Key slides for Euroapi S.A.


H1 2025
Euroapi S.A.


H1 2025
Euroapi S.A.
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
EAPI
Country
🇫🇷 France